Cisen Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 869.77 million compared to CNY 873.71 million a year ago. Net income was CNY 96.75 million compared to CNY 108.69 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.24 a year ago.